Active 0 6 0 6 O
CNS 7 10 7 10 B-chronic_disease
disease 11 18 11 18 I-chronic_disease
as 19 21 19 21 O
identified 22 32 22 32 O
by 33 35 33 35 O
positive 36 44 36 44 O
CSF 45 48 45 48 O
cytospin 49 57 49 57 O
at 58 60 58 60 O
time 61 65 61 65 O
of 66 68 66 68 O
enrollment 69 79 69 79 O

Alanine 0 7 80 87 B-clinical_variable
aminotransferase 8 24 88 104 I-clinical_variable
( 25 26 105 106 I-clinical_variable
ALT 26 29 106 109 I-clinical_variable
) 29 30 109 110 I-clinical_variable
and 31 34 111 114 O
aspartate 35 44 115 124 B-clinical_variable
aminotransferase 45 61 125 141 I-clinical_variable
( 62 63 142 143 I-clinical_variable
AST 63 66 143 146 I-clinical_variable
) 66 67 146 147 I-clinical_variable
> 68 69 148 149 O
= 69 70 149 150 O
3 71 72 151 152 B-lower_bound
x 73 74 153 154 I-lower_bound
the 75 78 155 158 I-lower_bound
upper 79 84 159 164 I-lower_bound
limit 85 90 165 170 I-lower_bound
of 91 93 171 173 I-lower_bound
normal 94 100 174 180 I-lower_bound

Creatinine 0 10 181 191 B-clinical_variable
clearance 11 20 192 201 I-clinical_variable
< 21 22 202 203 O
50 23 25 204 206 B-upper_bound
mL 26 28 207 209 I-upper_bound
/ 28 29 209 210 I-upper_bound
min/1.73m^2 29 40 210 221 I-upper_bound

Diffusion 0 9 222 231 B-clinical_variable
capacity 10 18 232 240 I-clinical_variable
of 19 21 241 243 I-clinical_variable
the 22 25 244 247 I-clinical_variable
lung 26 30 248 252 I-clinical_variable
for 31 34 253 256 I-clinical_variable
carbon 35 41 257 263 I-clinical_variable
monoxide 42 50 264 272 I-clinical_variable
( 51 52 273 274 I-clinical_variable
DLCO 52 56 274 278 I-clinical_variable
) 56 57 278 279 I-clinical_variable
< 58 59 280 281 O
40 60 62 282 284 B-upper_bound
% 62 63 284 285 I-upper_bound

Donors 0 6 286 292 O
must 7 11 293 297 O
be 12 14 298 300 O
> 15 16 301 302 O
= 16 17 302 303 O
17 18 20 304 306 B-lower_bound
years 21 26 307 312 I-lower_bound
of 27 29 313 315 O
age 30 33 316 319 B-age

Donors 0 6 320 326 O
receiving 7 16 327 336 O
experimental 17 29 337 349 B-treatment
therapy 30 37 350 357 I-treatment
or 38 40 358 360 O
investigational 41 56 361 376 B-treatment
agents 57 63 377 383 I-treatment
unless 64 70 384 390 O
approved 71 79 391 399 O
by 80 82 400 402 O
the 83 86 403 406 O
protocol 87 95 407 415 O
chair 96 101 416 421 O

Females 0 7 422 429 B-gender
who 8 11 430 433 O
are 12 15 434 437 O
pregnant 16 24 438 446 B-pregnancy
( 25 26 447 448 O
positive 26 34 448 456 O
serum 35 40 457 462 B-clinical_variable
beta 41 45 463 467 I-clinical_variable
human 46 51 468 473 I-clinical_variable
chorionic 52 61 474 483 I-clinical_variable
gonadotropin 62 74 484 496 I-clinical_variable
beta 75 79 497 501 I-clinical_variable
[ 80 81 502 503 I-clinical_variable
Î² 81 82 503 504 I-clinical_variable
HCG 83 86 505 508 I-clinical_variable
] 86 87 508 509 I-clinical_variable
) 87 88 509 510 O
or 89 91 511 513 O
uninterruptible 92 107 514 529 O
breastfeeding 108 121 530 543 O

Females 0 7 544 551 B-gender
who 8 11 552 555 O
are 12 15 556 559 B-pregnancy
pregnant 16 24 560 568 I-pregnancy
or 25 27 569 571 O
breastfeeding 28 41 572 585 O

Fertile 0 7 586 593 O
men 8 11 594 597 B-gender
and 12 15 598 601 I-gender
women 16 21 602 607 I-gender
unwilling 22 31 608 617 B-contraception_consent
to 32 34 618 620 I-contraception_consent
use 35 38 621 624 I-contraception_consent
contraceptive 39 52 625 638 I-contraception_consent
techniques 53 63 639 649 I-contraception_consent
during 64 70 650 656 O
and 71 74 657 660 O
for 75 78 661 664 O
12 79 81 665 667 B-upper_bound
months 82 88 668 674 I-upper_bound
following 89 98 675 684 O
treatment 99 108 685 694 B-treatment

For 0 3 695 698 O
patients 4 12 699 707 O
receiving 13 22 708 717 O
treatment 23 32 718 727 B-treatment
of 33 35 728 730 O
their 36 41 731 736 O
AML 42 45 737 740 B-cancer
, 45 46 740 741 O
MDS 47 50 742 745 B-cancer
or 51 53 746 748 O
ALL 54 57 749 752 B-cancer
prior 58 63 753 758 O
to 64 66 759 761 O
transplantation 67 82 762 777 B-treatment

Forced 0 6 778 784 B-clinical_variable
expiratory 7 17 785 795 I-clinical_variable
volume 18 24 796 802 I-clinical_variable
in 25 27 803 805 I-clinical_variable
one 28 31 806 809 I-clinical_variable
second 32 38 810 816 I-clinical_variable
( 39 40 817 818 I-clinical_variable
FEV1 40 44 818 822 I-clinical_variable
) 44 45 822 823 I-clinical_variable
< 46 47 824 825 O
50 48 50 826 828 B-upper_bound
% 50 51 828 829 I-upper_bound
( 52 53 830 831 O
corrected 53 62 831 840 O
for 63 66 841 844 O
hemoglobin 67 77 845 855 B-clinical_variable
) 77 78 855 856 O

HIV 0 3 857 860 B-chronic_disease
seropositive 4 16 861 873 I-chronic_disease

Hematopoietic 0 13 874 887 B-clinical_variable
Cell 14 18 888 892 I-clinical_variable
Transplantation 19 34 893 908 I-clinical_variable
- 34 35 908 909 I-clinical_variable
Specific 35 43 909 917 I-clinical_variable
Comorbidity 44 55 918 929 I-clinical_variable
Index 56 61 930 935 I-clinical_variable
score 62 67 936 941 I-clinical_variable
( 68 69 942 943 I-clinical_variable
HCT 69 72 943 946 I-clinical_variable
- 72 73 946 947 I-clinical_variable
CI 73 75 947 949 I-clinical_variable
) 75 76 949 950 I-clinical_variable
= 77 78 951 952 O
< 78 79 952 953 O
4 80 81 954 955 O
for 82 85 956 959 O
patients 86 94 960 968 O
in 95 97 969 971 O
Cohort 98 104 972 978 O
1 105 106 979 980 O
and 107 110 981 984 O
> 111 112 985 986 O
4 113 114 987 988 O
for 115 118 989 992 O
Cohort 119 125 993 999 O
2 126 127 1000 1001 O

High 0 4 1002 1006 O
resolution 5 15 1007 1017 O
typing 16 22 1018 1024 O
at 23 25 1025 1027 O
HLA 26 29 1028 1031 B-clinical_variable
- 29 30 1031 1032 I-clinical_variable
A 30 31 1032 1033 I-clinical_variable
, 31 32 1033 1034 I-clinical_variable
B 33 34 1035 1036 I-clinical_variable
, 34 35 1036 1037 I-clinical_variable
C 36 37 1038 1039 I-clinical_variable
and 38 41 1040 1043 O
DRB1 42 46 1044 1048 B-clinical_variable
alleles 47 54 1049 1056 I-clinical_variable

If 0 2 1057 1059 O
the 3 6 1060 1063 O
patient 7 14 1064 1071 O
has 15 18 1072 1075 O
an 19 21 1076 1078 O
intra 22 27 1079 1084 O
- 27 28 1084 1085 O
abdominal 28 37 1085 1094 O
chloroma 38 46 1095 1103 O
on 47 49 1104 1106 O
presentation 50 62 1107 1119 O
, 62 63 1119 1120 O
and 64 67 1121 1124 O
has 68 71 1125 1128 O
a 72 73 1129 1130 O
partial 74 81 1131 1138 O
response 82 90 1139 1147 O
or 91 93 1148 1150 O
complete 94 102 1151 1159 O
response 103 111 1160 1168 O
to 112 114 1169 1171 O
treatment 115 124 1172 1181 B-treatment
( 125 126 1182 1183 O
size 126 130 1183 1187 O
reduction 131 140 1188 1197 O
of 141 143 1198 1200 O
chloroma 144 152 1201 1209 O
and 153 156 1210 1213 O
marrow 157 163 1214 1220 B-clinical_variable
blast 164 169 1221 1226 I-clinical_variable
< 170 171 1227 1228 O
10 172 174 1229 1231 B-upper_bound
% 174 175 1231 1232 I-upper_bound
) 175 176 1232 1233 O
, 176 177 1233 1234 O
the 178 181 1235 1238 O
patient 182 189 1239 1246 O
is 190 192 1247 1249 O
eligible 193 201 1250 1258 O

Interval 0 8 1259 1267 O
between 9 16 1268 1275 O
completing 17 27 1276 1286 O
treatment 28 37 1287 1296 B-treatment
with 38 42 1297 1301 I-treatment
a 43 44 1302 1303 I-treatment
hypomethylating 45 60 1304 1319 I-treatment
agent 61 66 1320 1325 I-treatment
or 67 69 1326 1328 I-treatment
other 70 75 1329 1334 I-treatment
non 76 79 1335 1338 I-treatment
- 79 80 1338 1339 I-treatment
cytotoxic 80 89 1339 1348 I-treatment
chemotherapy 90 102 1349 1361 I-treatment
and 103 106 1362 1365 O
the 107 110 1366 1369 O
start 111 116 1370 1375 O
of 117 119 1376 1378 O
conditioning 120 132 1379 1391 O
regimen 133 140 1392 1399 O
must 141 145 1400 1404 O
be 146 148 1405 1407 O
at 149 151 1408 1410 O
least 152 157 1411 1416 O
10 158 160 1417 1419 B-lower_bound
days 161 165 1420 1424 I-lower_bound

Interval 0 8 1425 1433 O
between 9 16 1434 1441 O
the 17 20 1442 1445 O
start 21 26 1446 1451 O
of 27 29 1452 1454 O
a 30 31 1455 1456 O
cycle 32 37 1457 1462 O
of 38 40 1463 1465 O
conventional 41 53 1466 1478 B-treatment
cytotoxic 54 63 1479 1488 I-treatment
chemotherapy 64 76 1489 1501 I-treatment
and 77 80 1502 1505 O
the 81 84 1506 1509 O
start 85 90 1510 1515 O
of 91 93 1516 1518 O
conditioning 94 106 1519 1531 O
regimen 107 114 1532 1539 O
must 115 119 1540 1544 O
be 120 122 1545 1547 O
at 123 125 1548 1550 O
least 126 131 1551 1556 O
30 132 134 1557 1559 B-lower_bound
days 135 139 1560 1564 I-lower_bound

Karnofsky 0 9 1565 1574 B-clinical_variable
performance 10 21 1575 1586 I-clinical_variable
score 22 27 1587 1592 I-clinical_variable
< 28 29 1593 1594 O
70 30 32 1595 1597 B-upper_bound

Patient 0 7 1598 1605 O
must 8 12 1606 1610 O
be 13 15 1611 1613 O
able 16 20 1614 1618 O
to 21 23 1619 1621 O
lie 24 27 1622 1625 O
still 28 33 1626 1631 O
in 34 36 1632 1634 O
full 37 41 1635 1639 O
body 42 46 1640 1644 O
cast 47 51 1645 1649 O
for 52 55 1650 1653 O
45 56 58 1654 1656 B-upper_bound
minutes 59 66 1657 1664 I-upper_bound

Patients 0 8 1665 1673 O
seropositive 9 21 1674 1686 O
for 22 25 1687 1690 O
the 26 29 1691 1694 O
human 30 35 1695 1700 B-chronic_disease
immunodeficiency 36 52 1701 1717 I-chronic_disease
virus 53 58 1718 1723 I-chronic_disease
( 59 60 1724 1725 I-chronic_disease
HIV 60 63 1725 1728 I-chronic_disease
) 63 64 1728 1729 I-chronic_disease

Patients 0 8 1730 1738 O
who 9 12 1739 1742 O
had 13 16 1743 1746 O
prior 17 22 1747 1752 B-treatment
radiation 23 32 1753 1762 I-treatment
to 33 35 1763 1765 O
more 36 40 1766 1770 O
than 41 45 1771 1775 O
20 46 48 1776 1778 B-lower_bound
% 48 49 1778 1779 I-lower_bound
bone 50 54 1780 1784 O
marrow 55 61 1785 1791 O
containing 62 72 1792 1802 O
areas 73 78 1803 1808 O
or 79 81 1809 1811 O
to 82 84 1812 1814 O
any 85 88 1815 1818 O
areas 89 94 1819 1824 O
exceeding 95 104 1825 1834 O
2000 105 109 1835 1839 O
cGy 110 113 1840 1843 O

Patients 0 8 1844 1852 O
with 9 13 1853 1857 O
a 14 15 1858 1859 O
diagnosis 16 25 1860 1869 O
of 26 28 1870 1872 O
acute 29 34 1873 1878 B-cancer
myeloid 35 42 1879 1886 I-cancer
leukemia 43 51 1887 1895 I-cancer
( 52 53 1896 1897 I-cancer
AML 53 56 1897 1900 I-cancer
) 56 57 1900 1901 I-cancer
, 57 58 1901 1902 O
acute 59 64 1903 1908 B-cancer
lymphoblastic 65 78 1909 1922 I-cancer
leukemia 79 87 1923 1931 I-cancer
( 88 89 1932 1933 I-cancer
ALL 89 92 1933 1936 I-cancer
) 92 93 1936 1937 I-cancer
, 93 94 1937 1938 O
or 95 97 1939 1941 O
myelodysplastic 98 113 1942 1957 B-cancer
syndromes 114 123 1958 1967 I-cancer
( 124 125 1968 1969 I-cancer
MDS 125 128 1969 1972 I-cancer
) 128 129 1972 1973 I-cancer
with 130 134 1974 1978 O
fewer 135 140 1979 1984 O
than 141 145 1985 1989 O
10 146 148 1990 1992 B-upper_bound
% 148 149 1992 1993 I-upper_bound
myeloblasts 150 161 1994 2005 B-cancer
or 162 164 2006 2008 O
lymphoblasts 165 177 2009 2021 B-cancer
in 178 180 2022 2024 O
the 181 184 2025 2028 O
bone 185 189 2029 2033 O
marrow 190 196 2034 2040 O
and 197 200 2041 2044 O
no 201 203 2045 2047 O
blasts 204 210 2048 2054 O
in 211 213 2055 2057 O
the 214 217 2058 2061 O
peripheral 218 228 2062 2072 O
blood 229 234 2073 2078 O
on 235 237 2079 2081 O
morphologic 238 249 2082 2093 O
analysis 250 258 2094 2102 O
performed 259 268 2103 2112 O
within 269 275 2113 2119 O
30 276 278 2120 2122 B-upper_bound
days 279 283 2123 2127 I-upper_bound
of 284 286 2128 2130 O
start 287 292 2131 2136 O
of 293 295 2137 2139 O
the 296 299 2140 2143 O
conditioning 300 312 2144 2156 O
regimen 313 320 2157 2164 O

Patients 0 8 2165 2173 O
with 9 13 2174 2178 O
active 14 20 2179 2185 O
uncontrolled 21 33 2186 2198 O
bacterial 34 43 2199 2208 B-chronic_disease
, 43 44 2208 2209 O
viral 45 50 2210 2215 B-chronic_disease
or 51 53 2216 2218 O
fungal 54 60 2219 2225 B-chronic_disease
infections 61 71 2226 2236 I-chronic_disease
( 72 73 2237 2238 O
undergoing 73 83 2238 2248 O
appropriate 84 95 2249 2260 O
treatment 96 105 2261 2270 B-treatment
and 106 109 2271 2274 O
with 110 114 2275 2279 O
progression 115 126 2280 2291 O
of 127 129 2292 2294 O
clinical 130 138 2295 2303 O
symptoms 139 147 2304 2312 O
) 147 148 2312 2313 O

Patients 0 8 2314 2322 O
with 9 13 2323 2327 O
leukemia 14 22 2328 2336 B-cancer
infiltration 23 35 2337 2349 O
in 36 38 2350 2352 O
the 39 42 2353 2356 O
central 43 50 2357 2364 O
nervous 51 58 2365 2372 O
system 59 65 2373 2379 O
( 66 67 2380 2381 O
CNS 67 70 2381 2384 O
) 70 71 2384 2385 O
are 72 75 2386 2389 O
eligible 76 84 2390 2398 O
if 85 87 2399 2401 O
cerebrospinal 88 101 2402 2415 B-treatment
fluid 102 107 2416 2421 I-treatment
( 108 109 2422 2423 I-treatment
CSF 109 112 2423 2426 I-treatment
) 112 113 2426 2427 I-treatment
cytospin 114 122 2428 2436 I-treatment
is 123 125 2437 2439 O
negative 126 134 2440 2448 O
for 135 138 2449 2452 O
myeloblasts 139 150 2453 2464 O
or 151 153 2465 2467 O
lymphoblasts 154 166 2468 2480 O
at 167 169 2481 2483 O
time 170 174 2484 2488 O
of 175 177 2489 2491 O
enrollment 178 188 2492 2502 O

Pre 0 3 2503 2506 O
- 3 4 2506 2507 O
transplant 4 14 2507 2517 B-treatment
bone 15 19 2518 2522 O
marrow 20 26 2523 2529 O
sample 27 33 2530 2536 O
must 34 38 2537 2541 O
be 39 41 2542 2544 O
evaluable 42 51 2545 2554 O
for 52 55 2555 2558 O
assessment 56 66 2559 2569 O
of 67 69 2570 2572 O
remission 70 79 2573 2582 O
status 80 86 2583 2589 O
( 87 88 2590 2591 O
i.e. 88 92 2591 2595 O
aspirate 93 101 2596 2604 O
smear 102 107 2605 2610 O
containing 108 118 2611 2621 O
particles 119 128 2622 2631 O
and/or 129 135 2632 2638 O
evaluable 136 145 2639 2648 O
bone 146 150 2649 2653 B-treatment
marrow 151 157 2654 2660 I-treatment
core 158 162 2661 2665 I-treatment
biopsy 163 169 2666 2672 I-treatment
) 169 170 2672 2673 O

Prior 0 5 2674 2679 B-treatment
allograft 6 15 2680 2689 I-treatment
or 16 18 2690 2692 O
prior 19 24 2693 2698 B-treatment
autograft 25 34 2699 2708 I-treatment

Receiving 0 9 2709 2718 O
supplementary 10 23 2719 2732 B-treatment
continuous 24 34 2733 2743 I-treatment
oxygen 35 41 2744 2750 I-treatment

Symptomatic 0 11 2751 2762 O
uncontrolled 12 24 2763 2775 O
coronary 25 33 2776 2784 B-chronic_disease
artery 34 40 2785 2791 I-chronic_disease
disease 41 48 2792 2799 I-chronic_disease
or 49 51 2800 2802 O
ejection 52 60 2803 2811 B-chronic_disease
fraction 61 69 2812 2820 I-chronic_disease
< 70 71 2821 2822 O
40 72 74 2823 2825 B-upper_bound
% 74 75 2825 2826 I-upper_bound

Total 0 5 2827 2832 B-clinical_variable
bilirubin 6 15 2833 2842 I-clinical_variable
> 16 17 2843 2844 O
= 17 18 2844 2845 O
2 19 20 2846 2847 B-lower_bound
x 21 22 2848 2849 I-lower_bound
the 23 26 2850 2853 I-lower_bound
upper 27 32 2854 2859 I-lower_bound
limit 33 38 2860 2865 I-lower_bound
of 39 41 2866 2868 I-lower_bound
normal 42 48 2869 2875 I-lower_bound

chloroma 0 8 2876 2884 B-cancer
must 9 13 2885 2889 O
be 14 16 2890 2892 O
included 17 25 2893 2901 O
as 26 28 2902 2904 O
part 29 33 2905 2909 O
of 34 36 2910 2912 O
the 37 40 2913 2916 O
treatment 41 50 2917 2926 B-treatment
target 51 57 2927 2933 O

if 0 2 2934 2936 O
remission 3 12 2937 2946 O
bone 13 17 2947 2951 O
marrow 18 24 2952 2958 O
is 25 27 2959 2961 O
available 28 37 2962 2971 O
beyond 38 44 2972 2978 B-upper_bound
30 45 47 2979 2981 I-upper_bound
days 48 52 2982 2986 I-upper_bound
a 53 54 2987 2988 O
new 55 58 2989 2992 O
bone 59 63 2993 2997 O
marrow 64 70 2998 3004 O
evaluation 71 81 3005 3015 O
is 82 84 3016 3018 O
required 85 93 3019 3027 O
to 94 96 3028 3030 O
assess 97 103 3031 3037 O
remission 104 113 3038 3047 O
status 114 120 3048 3054 O

irculating 0 10 3055 3065 O
peripheral 11 21 3066 3076 O
blood 22 27 3077 3082 O
myeloblasts 28 39 3083 3094 B-cancer
or 40 42 3095 3097 O
lymphoblasts 43 55 3098 3110 B-cancer
on 56 58 3111 3113 O
morphologic 59 70 3114 3125 O
analysis 71 79 3126 3134 O
from 80 84 3135 3139 O
time 85 89 3140 3144 O
of 90 92 3145 3147 O
last 93 97 3148 3152 O
treatment 98 107 3153 3162 B-treatment
to 108 110 3163 3165 O
time 111 115 3166 3170 O
of 116 118 3171 3173 O
enrollment 119 129 3174 3184 O

